SCPS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SCPS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Scopus BioPharma's other long-term assets for the quarter that ended in Jun. 2023 was $0.00 Mil.
Scopus BioPharma's quarterly other long-term assets stayed the same from Dec. 2022 ($0.00 Mil) to Mar. 2023 ($0.00 Mil) and stayed the same from Mar. 2023 ($0.00 Mil) to Jun. 2023 ($0.00 Mil).
Scopus BioPharma's annual other long-term assets increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil).
The historical data trend for Scopus BioPharma's Other Long Term Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scopus BioPharma Annual Data | |||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||
Other Long Term Assets | Get a 7-Day Free Trial | - | - | - | - | - |
Scopus BioPharma Quarterly Data | ||||||||||||||||||||
Jun18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Other Long Term Assets | Get a 7-Day Free Trial | - | - | - | - | - |
GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.
Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.
Ira Scott Greenspan | director | 888 SEVENTH AVENUE, 9TH FLOOR, NEW YORK NY 10106 |
Joshua R Lamstein | director, officer: Chairman | 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10170 |
Alan M Horsager | officer: See Remarks | 1021 N EVERETT STREET, GLENDALE CA 91207 |
Robert J Gibson | director, officer: Vice Chairman | 71 LANTERN RIDGE RD, NEW CANAAN CT 06840 |
Lesley Russell | director | 41 MOORES RD., FRAZER PA 19355 |
Iv David Weild | director | 22 ORIOLE AVENUE, BRONXVILLE NY 10708 |
David S. Battleman | director | C/O TRUENORTH LIFESCIENCES, 348 WEST 57TH STREET, #226, NEW YORK NY 10019 |
David A. Buckel | director | SHARPSPRING, 550 SW 2ND AVENUE, GAINESVILLE FL 32601 |
Raphael Hofstein | director | C/O HADASSAH, P.O. BOX 12000, JERUSALEM L3 91120 |
Paul Hopper | director | 7982 DOUG HILL, SAN DIEGO CA 92127 |
Ashish P Sanghrajka | director, officer: President | 101 WALL STREET, APARTMENT 19B, NEW YORK NY 10005 |
From GuruFocus
By Marketwired Marketwired • 10-01-2021
By Marketwired Marketwired • 10-08-2021
By Marketwired Marketwired • 09-28-2021
By Marketwired Marketwired • 09-29-2021
By Marketwired Marketwired • 09-28-2021
By Don Li2 Don Li2 • 11-08-2021
By Marketwired Marketwired • 09-14-2021
By Marketwired Marketwired • 10-05-2021
By GuruFocusNews GuruFocusNews • 03-23-2022
By GlobeNewswire GlobeNewswire • 10-08-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.